STOCK TITAN

Hawkins Inc Form 4 Filings

HWKN NASDAQ

Every Form 4 that Hawkins Inc (HWKN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow HWKN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HWKN filings page.

Rhea-AI Summary

HAWKINS INC (HWKN) executive vice president and CFO Jeffrey P. Oldenkamp reported an open-market purchase of 1,290 shares of common stock on August 27, 2026 at $119.00 per share. After this transaction, he held 104,223.101 shares directly, including shares acquired through the dividend reinvestment and employee stock purchase plans, and 1,561.4324 shares indirectly through an ESOP trustee.

Rhea-AI Summary

HAWKINS INC (HWKN) reported an open-market purchase of its common stock by insider Douglas A. Lange, VP - Water Treatment Group. On August 25, 2026, Lange purchased 910 shares at a weighted average price of $118.7536 per share, with individual trade prices ranging from $118.61 to $118.84 per share. Following this transaction, he directly owned 28,168.8129 shares of common stock, which include 5.1019 shares acquired on June 12, 2026 under a dividend reinvestment plan and 107 shares acquired on June 30, 2026 under an employee stock purchase plan. He also held 821.7371 shares indirectly through an ESOP trustee and 941.2140 shares indirectly through an IRA.

Rhea-AI Summary

Hawkins Inc. CEO and President Patrick H. Hawkins reported a bona fide gift of 580 shares of common stock on August 7, 2026, made for no consideration. After this disposition, he directly holds 321,257.0494 shares, which include 4.1891 shares from a dividend reinvestment plan and 107 shares from an employee stock purchase plan, and indirectly holds 26,084.9395 shares through an ESOP trustee.

Rhea-AI Summary

Hawkins Inc director Mary J. Schumacher received a grant of 721 shares of common stock on 2026-07-29 at a stated price of $0.0000 per share, described as a grant or award acquisition. Following this award, her directly held position increased to 26,898 common shares.

The transaction was reported as an acquisition rather than a market purchase or sale and was not indicated as made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Faulconbridge James A reported acquisition or exercise transactions in this Form 4 filing.

Hawkins Inc director James A. Faulconbridge received an award of 721 shares of Common Stock on 2026-07-29. The shares were reported at a per-share value of $0.0000, indicating a grant or award rather than a market purchase. Following this transaction, he directly owns 53,128 shares of Hawkins Inc Common Stock.

Rhea-AI Summary

WRIGHT JEFFREY L reported acquisition or exercise transactions in this Form 4 filing.

Hawkins Inc director Jeffrey L. Wright received an equity grant of 721 shares of common stock on July 29, 2026, recorded at $0.00 per share. This award increased his directly held stake to 42,916 shares. The filing does not indicate use of a Rule 10b5-1 trading plan.

Rhea-AI Summary

Hawkins Inc director Tang Yi reported an equity award of 721 shares of common stock on July 29, 2026, recorded as a grant or award acquisition at $0.0000 per share. After this transaction, Tang Yi directly holds 8,612 shares of Hawkins common stock.

Rhea-AI Summary

Hawkins Inc director Jeffrey E. Spethmann received a grant of 721 shares of common stock on July 29, 2026, recorded at $0.00 per share. Following this award, he directly holds 6,639.103 shares, including 7.103 shares acquired June 15, 2026 under the dividend reinvestment plan.

Rhea-AI Summary

Stauber Daniel J reported acquisition or exercise transactions in this Form 4 filing.

Hawkins Inc director Daniel J Stauber received a grant of 721 shares of common stock on July 29, 2026 at $0.00 per share. Following this award, he directly holds 35,497.8812 shares, including 38.8082 shares from a dividend reinvestment plan and 175 shares from an employee stock purchase plan.

Rhea-AI Summary

Hawkins Inc director James T. Thompson reported a grant of 721 shares of Common Stock on 2026-07-29, classified as a grant, award, or other acquisition at a reported price of $0.0000 per share. After this award, his directly held Hawkins common shares stood at 38,916.

Rhea-AI Summary

HAWKINS INC vice president of Health and Nutrition, Shirley A. Rozeboom, reported routine equity compensation activity. She received a grant of 1,906 shares of Common Stock on May 13, 2026, bringing her direct holdings to 34,087.8625 shares. Earlier, on March 30, 2026, 3,608 shares were withheld at $151.62 per share to satisfy tax obligations, a non‑market disposition. Her holdings also reflect additional shares acquired through the issuer’s dividend reinvestment and employee stock purchase plans.

Rhea-AI Summary

Hawkins Inc. vice president Douglas A. Lange reported a stock award of 1,994 shares of common stock, received as a grant with no cash paid per share. After this compensation-related acquisition, his direct holdings total 27,146.711 shares. He also reports indirect holdings of 941.214 shares through an IRA and 756.2655 shares through an ESOP trustee.

Rhea-AI Summary

HAWKINS INC Executive VP and CFO Jeffrey P. Oldenkamp reported an equity compensation grant of common stock. He received 8,435 shares of Hawkins common stock as a grant, award, or other acquisition at a reported price of $0.00 per share, increasing his directly held stake to 102,818.4839 shares. A separate entry shows 1,495.9607 shares of common stock held indirectly "by ESOP Trustee," reflecting his interest in the company’s employee stock ownership plan.

Rhea-AI Summary

HAWKINS INC vice president of operations Drew M. Grahek reported a stock award of 2,697 shares of common stock at no cost. After this grant, he directly holds 37,135.5051 shares. He also has 905.4307 shares held indirectly through an ESOP trustee. The direct total includes shares acquired under the employee stock purchase plan and the dividend reinvestment plan.

Rhea-AI Summary

Mangine David J. reported acquisition or exercise transactions in this Form 4 filing.

Hawkins Inc. executive David J. Mangine reported an equity grant of common stock. On May 13, 2026, he received 1,906 shares of Hawkins common stock as a grant or award at $0.00 per share, increasing his direct holdings to 27,763.2393 shares.

In addition to these directly held shares, Mangine is also reported as having indirect ownership of 29.729 shares through a trust and 9,780.201 shares through an ESOP trustee. The filing shows no open‑market purchases or sales, indicating this is a compensation-related award rather than a discretionary trade.

Rhea-AI Summary

HAWKINS INC executive Gregory Alan Jones, VP of Food and Health Sciences, acquired 1,970 shares of common stock as a stock grant on May 13, 2026. The award was recorded at $0.00 per share, reflecting compensation rather than a market purchase.

After this grant, Jones directly holds 10,144.4943 common shares. This total includes 0.4943 shares accumulated through the company’s dividend reinvestment plan between August 2025 and February 2026, and 194 shares acquired via the employee stock purchase plan between June and December 2025.

Rhea-AI Summary

HAWKINS INC CEO and President Patrick H. Hawkins reported an equity award of 16,934 shares of Common Stock, received as a grant or other acquisition at a stated price of $0.00 per share. After this grant, he directly holds 321,725.8603 common shares. The filing also lists an indirect holding of 26,074.5547 common shares held "By ESOP Trustee," reflecting beneficial ownership through an employee stock ownership plan structure. No open-market purchases or sales are reported in this filing, and no derivative securities are shown as outstanding.

Rhea-AI Summary

Hawkins Inc. vice president Douglas A. Lange reported a tax-related share disposition linked to equity compensation. On March 30, 2026, 3,855 shares of Hawkins common stock were withheld at $151.62 per share to satisfy tax obligations, a non‑open‑market transaction.

After this withholding, Lange directly holds 25,152.711 shares of common stock. He also has indirect holdings of 756.2655 shares through an ESOP trustee and 941.2140 shares through an IRA. A footnote notes that the direct position includes shares acquired via a dividend reinvestment plan and an employee stock purchase plan.

Rhea-AI Summary

Hawkins Inc. vice president David J. Mangine had shares withheld to cover taxes, not as an open-market sale. On March 30, 2026, 3,493 shares of common stock were disposed of at $151.62 per share as a tax-withholding transaction related to equity compensation.

After this, he held 25,857.2393 shares directly, plus 9,780.2010 shares held indirectly through an ESOP trustee and 29.7290 shares held indirectly through a trust. A footnote notes additional shares previously acquired via dividend reinvestment and the employee stock purchase plan.

Rhea-AI Summary

Hawkins Inc. executive Jeffrey P. Oldenkamp, Executive VP and CFO, reported a tax-related share disposition rather than an open-market trade. On March 30, 2026, 5,675 shares of common stock were withheld at $151.62 per share to cover tax obligations.

After this withholding, Oldenkamp directly holds 94,383.4839 common shares. He also has an indirect position of 1,495.9607 shares held by an ESOP trustee, which includes 194 shares from the employee stock purchase plan and 32.3552 shares from the dividend reinvestment plan.

Rhea-AI Summary

Hawkins Inc. vice president of operations Drew M. Grahek had 3,818 shares of common stock withheld to cover tax obligations. The shares were valued at $151.62 each and this was not an open-market sale but a tax-withholding disposition related to equity compensation.

After this withholding, he directly holds 34,438.5051 Hawkins shares and indirectly holds 905.4307 shares through an ESOP trustee. A footnote notes that his direct holdings include 68 shares from an employee stock purchase plan and 4.1145 shares from a dividend reinvestment plan.

Rhea-AI Summary

Hawkins Inc CEO and President Patrick H. Hawkins reported a tax-withholding disposition of 10,950 shares of Common Stock at $151.62 per share. The shares were delivered to satisfy tax obligations rather than sold in the open market.

After this transaction, he directly owns 304,791.8603 Hawkins Inc shares and indirectly owns 26,074.5547 shares through an ESOP trustee. A footnote notes that 4.4988 of these shares were acquired on February 27, 2026 via the company’s dividend reinvestment plan.

Rhea-AI Summary

Hawkins Inc director and CEO Patrick H. Hawkins reported gifting common stock and updating his holdings. On February 23, 2026, he made two bona fide gifts totaling 1,300 shares of Hawkins common stock for no consideration, classified as dispositions by gift.

After these transfers, his directly held ownership was 315,477.3615 shares of common stock. He also reported 26,074.5547 shares held indirectly "By ESOP Trustee," reflecting shares associated with an employee stock ownership plan.

Rhea-AI Summary

Hawkins Inc. director James A. Faulconbridge reported open-market purchases of company common stock. On February 4, 2026, he bought 1,500 shares at $129.29 per share. On February 5, 2026, he bought another 1,500 shares at $129.95, increasing his directly held stake to 52,407 shares.

Rhea-AI Summary

Hawkins Inc’s vice president of operations reported gifting 1,460 shares of common stock on December 9, 2025, using transaction code G. The shares were reported at a price of $ 126.3425 per share. After this transfer, the executive holds 38,184.3906 shares directly and 905.4307 shares indirectly through an ESOP trustee. The direct holdings include 4.5075 shares acquired on November 28, 2025 under the company’s dividend reinvestment plan.

Rhea-AI Summary

Hawkins Inc. (HWKN) insider filing: The company’s VP, General Counsel & Secretary reported a bona fide gift of 50 shares of common stock on 11/12/2025 (Code G) at a stated price of $0.

Following the transaction, the reporting person beneficially owns 64,781.5679 shares directly and 2,450.1317 shares indirectly through the ESOP Trustee. The filing notes prior routine acquisitions: 20.0356 shares via the dividend reinvestment plan (June–August 2025) and 64 shares via the employee stock purchase plan on June 30, 2025.

Rhea-AI Summary

Hawkins, Inc. (HWKN) reported an insider purchase. The Vice President of Operations bought 1,587 shares of common stock on 11/03/2025 in an open‑market transaction (Code P) at an average price of $126.3425 per share.

Following the trade, the officer beneficially owned 39,639.8831 shares directly and 905.4307 shares indirectly through the ESOP trustee. A footnote notes additional shares previously acquired via the dividend reinvestment plan and the employee stock purchase plan.